Speaker Series: Treatment switching in virologically suppressed HIV patients

In this review:

This review is a summary of a recent Auckland Journal Club presentation by Dr Fraser Drummond, Medical Director Australasia at ViiV Healthcare. Dr Drummond discussed the scientific and clinical evidence for switching to dolutegravir (DTG) in the treatment-experienced HIV patient in the setting of virological suppression.

Download PDF Subscribe